Philip Bright

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Vaccination, Vaccine Safety, Phase 1/2 +7

Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa

Síle F. Molloy, Cecilia Kanyama, Robert S. Heyderman et al. · New England Journal of Medicine · 2018 · 393 citations · Full text

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

Adrian Shields, Siobhan O. Burns, Sinisa Savic et al. · Journal of Allergy and Clinical Immunology · 2020 · 234 citations · Full text

Primary Immunodeficiency, Secondary Immunodeficiency, United Kingdom Experience +7

Occupational asthma due to glutaraldehyde and formaldehyde in endoscopy and x ray departments.

P F Gannon, Philip Bright, Morag H. Campbell et al. · Thorax · 1995 · 163 citations · Full text

Occupational asthma due to chrome and nickel electroplating

Philip Bright, Sherwood Burge, SP O'Hickey et al. · Thorax · 1997 · 118 citations · Full text